Global Newborn Screening Market Analysis and Forecast 2022 by Product, Technology, Types and Region

By | February 17, 2017

According to Stratistics MRC, the Global Newborn Screening market is accounted for $495.50 million in 2015 and is expected to reach $1,307.65 million by 2022 growing at a CAGR of 12.9%. In present scenario the Newborn baby is either being affected by the environmental conditions or born with some disorder, and hence the Newborn Screening market is helping out to detect those disorders. Recent technological advancements, government legislation & support, increasing awareness among people have given impetus to the market. However, Socio-Economic barriers and less trained professionals are some of the factors hindering the growth.

Browse a Report@ http://www.orbisresearch.com/reports/index/newborn-screening-global-market-outlook-2016-2022

Tandem Mass Spectrometry (TMS) segment is expected to account for highest CAGR, attributing to its time & cost effectiveness of the technology compared to other technologies available in this particular market. In addition to this, Dry Blood Spot Test type segment is expected to be the largest market owing to the technological advancements due to which new and advanced products are being launched in the market. North America is dominating the global market in order to the increasing prevalence of cardiovascular disorders and enforced testing. However, Asia Pacific is expected to present lenient growth, poised by the favorable healthcare.

Some of the key players of the Newborn Screening market include AB Sciex LLC, Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Covidien PLC, GE Healthcare, GE Lifesciences, Masimo Corporation, Natus Medical Incorporated, Perkinelmer, Inc., Trivitron Healthcare and Waters Corporation.

Product types Covered:
Newborn Hearing Screening Instruments
Hearing Screening Accessories
Hearing Screening Devices
Pulse Oximeters
Newborn Disorder Screening Instruments
Developmental
Genetic
Metabolic
Reagents and Assay Kits

Technologies Covered:
DNA-Based Assays
Electrophoresis
Hearing Screen Technology
Immunoassays and Enzymatic Assays
Pulse Oximetry Screening Technology
Tandem Mass Spectrometry (TMS)

Test Types Covered:
Critical Congenital Heart Diseases (CCHD) Test
Dry Blood Spot Test
Hearing Screen Test

Request a sample copy of Report @ http://www.orbisresearch.com/contacts/request-sample/184966

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

Buy a Report@ http://www.orbisresearch.com/contact/purchase/184966

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas – 75204, U.S.A.

Phone No.: +1 (214) 884-6817; +9164101019

Email:sales@orbisresearch.com

Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research

Follow us on Twitter: https://twitter.com/orbisresearch

Like us on Facebook: https://www.facebook.com/OrbisResearch

 

Leave a Reply

Your email address will not be published. Required fields are marked *